Please login to the form below

Not currently logged in
Email:
Password:

hepatitis B

This page shows the latest hepatitis B news and features for those working in and with pharma, biotech and healthcare.

Gilead targets hep B in half a billion dollar deal with Precision BioSciences

Gilead targets hep B in half a billion dollar deal with Precision BioSciences

Precision’s chief scientific officer, Derek Jantz commented: "Gilead's cure-based approach to hepatitis B is comprehensive and exciting. ... He said: “Gilead is committed to developing innovative therapies to achieve functional cure for patients with

Latest news

More from news
Approximately 6 fully matching, plus 84 partially matching documents found.

Latest Intelligence

  • No incentive for a cure No incentive for a cure

    Hepatitis C virus treatments like Maviret from AbbVie, which cures people with hard-to-treat genotype 3 after an 8. ... This is the route the NHS in the UK has taken with innovative hepatitis C treatments; it will only pay for the medication if a patient

  • Pharma deals in April 2015 Pharma deals in April 2015

    its SAR3419, an antibody-drug conjugate designed to treat diffuse large B-cell lymphoma (DLBCL) and other blood cancers. ... These are key markets for this product as more than 75% of all HCC cases occur in the APAC region, largely in association with

  • Deal Watch table for January 2015 Deal Watch table for January 2015

    Corporate acquisition. 545. Cytos Biotechnology/ OnCore. Access to virus like particle (VLP) platform for the treatment and prevention of hepatitis B with an option to other viral diseases.

  • Deal Watch table for September 2014 Deal Watch table for September 2014

    153. NeuroVive / OnCore. Licence and collaboration. NVP018 an oral sangamide-based 2nd generation cyclophilin inhibitor for hepatitis B.

  • Case study: Confront hepatitis Case study: Confront hepatitis

    Challenge. 500 million people globally are living with either chronic hepatitis B or C - while this is higher than those with HIV or any cancer, the disease is hugely underfunded, with ... Client verdict. Charles Gore, president of the World Hepatitis

More from intelligence
Approximately 2 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics